[31] Subsequently, several studies analyzed CD171 expression in 66-434 GIST cases and reported 55-59% of positivity with some studies suggesting the potential of CD171 expression for the prognostication of GIST. The gene discussed is L1CAM; the disease is gastrointestinal stromal tumor.